Literature DB >> 9789839

Medical management of organophosphate-induced seizures.

G Lallement1, F Dorandeu, P Filliat, P Carpentier, V Baille, G Blanchet.   

Abstract

Recent studies concerning management of soman-induced seizures are reviewed. While drugs classically used against epilepsy in hospital appear ineffective against soman, muscarinic receptor blockers are shown to be able to prevent or stop seizures within the first 5 min after their onset. Benzodiazepine could also be considered as an emergency treatment useful during the first 10 min of seizure. Comparatively NMDA antagonists appear to be able to terminate soman-induced seizures even if the treatment is delayed after 40 min of epileptic activity. Drugs with both antimuscarinic and anti-NMDA properties may represent the most adequate pharmacological treatment to treat soman intoxication. However, the results obtained until now with these drugs must be completed in relation with their possible efficacy after i.m. administration. Propositions for future studies are reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789839     DOI: 10.1016/S0928-4257(99)80007-2

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  18 in total

1.  The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Franco Rossetti; Steven L Miller; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2014-08-25       Impact factor: 4.030

2.  Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.

Authors:  T H Figueiredo; V Aroniadou-Anderjaska; F Qashu; J P Apland; V Pidoplichko; D Stevens; T M Ferrara; M F M Braga
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 3.  A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation.

Authors:  Christopher N Banks; Pamela J Lein
Journal:  Neurotoxicology       Date:  2012-02-10       Impact factor: 4.294

4.  Age-Related Susceptibility to Epileptogenesis and Neuronal Loss in Male Fischer Rats Exposed to Soman and Treated With Medical Countermeasures.

Authors:  Brenda Marrero-Rosado; Franco Rossetti; Matthew W Rice; Mark C Moffett; Robyn B Lee; Michael F Stone; Lucille A Lumley
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

5.  Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.

Authors:  Tetsade C B Piermartiri; Hongna Pan; Jun Chen; John McDonough; Neil Grunberg; James P Apland; Ann M Marini
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

6.  Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Volodymyr I Pidoplichko; Katia Rossetti; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2018-02-21       Impact factor: 4.030

Review 7.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

8.  The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Authors:  Taiza H Figueiredo; Felicia Qashu; James P Apland; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

9.  Protective effects of N-methyl-D-aspartate receptor antagonism on VX-induced neuronal cell death in cultured rat cortical neurons.

Authors:  Yushan Wang; M Tracy Weiss; Junfei Yin; Catherine C Tenn; Peggy D Nelson; John R Mikler
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

10.  LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.

Authors:  Eric M Prager; Taiza H Figueiredo; Robert P Long; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neuropharmacology       Date:  2014-09-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.